학술논문

PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
Document Type
Article
Source
In The Lancet Diabetes & Endocrinology March 2024 12(3):174-183
Subject
Primary Research
Articles
Language
ISSN
2213-8587